Characterization of Novel CB2 Agonist SMM-295 and Its Effects in Ischemia/Reperfusion Injury
Jeffrey D. Pressly(University of Tennessee Health Science Center)
Cited by 0
Related Papers
Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury
|Journal of Pharmacology and Experimental Therapeutics|2017|34
TRIP13-deficient tubular epithelial cells are susceptible to apoptosis following acute kidney injury
|Scientific Reports|2017|25